# Capital City Bank Group Inc: financial statements, quarterly

CCBG · Nasdaq · CIK 726601 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ccbg.md) · [Financials](/companies/ccbg/financials.md) · [Filings](/companies/ccbg/filings.md) · [Insiders](/companies/ccbg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ccbg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [5.1](/filings/0000726601-24-000033.md) | [6.5](/filings/0000726601-23-000054.md) | [7.0 d](/filings/0000726601-24-000023.md) | [8.5](/filings/0000726601-24-000024.md) | [9.5](/filings/0000726601-24-000033.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [3.4](/filings/0000726601-24-000033.md) | [3.0](/filings/0000726601-24-000040.md) | [2.9 d](/filings/0000726601-26-000007.md) | [3.5](/filings/0000726601-25-000018.md) | [3.2](/filings/0000726601-25-000036.md) | [3.0](/filings/0000726601-25-000042.md) | [4.2 d](/filings/0000726601-26-000007.md) | [5.1](/filings/0000726601-26-000011.md) | [5.0](/filings/0000726601-25-000036.md) | [5.1](/filings/0000726601-25-000042.md) | [4.9 d](/filings/0000726601-26-000007.md) | [4.8](/filings/0000726601-26-000011.md) |
| Net income | $m | [14.2](/filings/0000726601-24-000033.md) | [12.7](/filings/0000726601-24-000040.md) | [11.7 d](/filings/0000726601-26-000007.md) | [12.6](/filings/0000726601-25-000018.md) | [14.2](/filings/0000726601-25-000036.md) | [13.1](/filings/0000726601-25-000042.md) | [13.1 d](/filings/0000726601-26-000007.md) | [16.9](/filings/0000726601-26-000011.md) | [15.0](/filings/0000726601-25-000036.md) | [16.0](/filings/0000726601-25-000042.md) | [13.7 d](/filings/0000726601-26-000007.md) | [15.8](/filings/0000726601-26-000011.md) |
| Diluted EPS | $ per share | [0.83](/filings/0000726601-24-000033.md) | [0.74](/filings/0000726601-24-000040.md) | not reported | [0.74](/filings/0000726601-25-000018.md) | [0.83](/filings/0000726601-25-000036.md) | [0.77](/filings/0000726601-25-000042.md) | not reported | [0.99](/filings/0000726601-26-000011.md) | [0.88](/filings/0000726601-25-000036.md) | [0.93](/filings/0000726601-25-000042.md) | not reported | [0.92](/filings/0000726601-26-000011.md) |
| Basic EPS | $ per share | [0.83](/filings/0000726601-24-000033.md) | [0.75](/filings/0000726601-24-000040.md) | not reported | [0.74](/filings/0000726601-25-000018.md) | [0.84](/filings/0000726601-25-000036.md) | [0.77](/filings/0000726601-25-000042.md) | not reported | [0.99](/filings/0000726601-26-000011.md) | [0.88](/filings/0000726601-25-000036.md) | [0.93](/filings/0000726601-25-000042.md) | not reported | [0.92](/filings/0000726601-26-000011.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | [4,391](/filings/0000726601-23-000051.md) | [4,138](/filings/0000726601-23-000054.md) | [4,304](/filings/0000726601-25-000013.md) | [4,260](/filings/0000726601-24-000024.md) | [4,226](/filings/0000726601-24-000033.md) | [4,225](/filings/0000726601-24-000040.md) | [4,325](/filings/0000726601-26-000007.md) | [4,461](/filings/0000726601-25-000018.md) | [4,392](/filings/0000726601-25-000036.md) | [4,324](/filings/0000726601-25-000042.md) | [4,386](/filings/0000726601-26-000011.md) | [4,454](/filings/0000726601-26-000011.md) |
| Total liabilities | $m | [3,970](/filings/0000726601-23-000051.md) | [3,711](/filings/0000726601-23-000054.md) | [3,856](/filings/0000726601-25-000013.md) | [3,805](/filings/0000726601-24-000024.md) | [3,758](/filings/0000726601-24-000033.md) | [3,742](/filings/0000726601-24-000040.md) | [3,830](/filings/0000726601-26-000007.md) | [3,949](/filings/0000726601-25-000018.md) | [3,865](/filings/0000726601-25-000036.md) | [3,783](/filings/0000726601-25-000042.md) | [3,833](/filings/0000726601-26-000011.md) | [3,894](/filings/0000726601-26-000011.md) |
| Long-term debt | $m | not reported | not reported | [0.3](/filings/0000726601-24-000023.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [50.7](/filings/0000726601-23-000051.md) | [41.7](/filings/0000726601-23-000054.md) | [35.3](/filings/0000726601-25-000013.md) | [31.9](/filings/0000726601-24-000024.md) | [25.8](/filings/0000726601-24-000033.md) | [37.3](/filings/0000726601-24-000040.md) | [28.3](/filings/0000726601-26-000007.md) | [37.2](/filings/0000726601-25-000018.md) | [34.5](/filings/0000726601-25-000036.md) | [40.2](/filings/0000726601-25-000042.md) | [50.1](/filings/0000726601-26-000011.md) | [33.3](/filings/0000726601-26-000011.md) |
| Shareholders' equity | $m | [412](/filings/0000726601-24-000040.md) | [420](/filings/0000726601-24-000040.md) | [441](/filings/0000726601-26-000007.md) | [448](/filings/0000726601-25-000036.md) | [461](/filings/0000726601-25-000042.md) | [476](/filings/0000726601-25-000042.md) | [495](/filings/0000726601-26-000011.md) | [513](/filings/0000726601-26-000011.md) | [526](/filings/0000726601-25-000042.md) | [541](/filings/0000726601-25-000042.md) | [553](/filings/0000726601-26-000011.md) | [560](/filings/0000726601-26-000011.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [4.2 d](/filings/0000726601-24-000033.md) | [25.3 d](/filings/0000726601-24-000040.md) | [4.6 d](/filings/0000726601-26-000007.md) | [14.6](/filings/0000726601-25-000018.md) | [24.9 d](/filings/0000726601-25-000036.md) | [12.8 d](/filings/0000726601-25-000042.md) | [11.2 d](/filings/0000726601-26-000007.md) | [21.9](/filings/0000726601-26-000011.md) | [32.6 d](/filings/0000726601-25-000036.md) | [21.6 d](/filings/0000726601-25-000042.md) | [11.6 d](/filings/0000726601-26-000007.md) | [15.9](/filings/0000726601-26-000011.md) |
| Capital expenditure | $m | [2.0 d](/filings/0000726601-24-000033.md) | [1.6 d](/filings/0000726601-24-000040.md) | [1.6 d](/filings/0000726601-26-000007.md) | [2.2](/filings/0000726601-25-000018.md) | [2.0 d](/filings/0000726601-25-000036.md) | [2.2 d](/filings/0000726601-25-000042.md) | [2.2 d](/filings/0000726601-26-000007.md) | [2.4](/filings/0000726601-26-000011.md) | [1.8 d](/filings/0000726601-25-000036.md) | [1.7 d](/filings/0000726601-25-000042.md) | [1.6 d](/filings/0000726601-26-000007.md) | [1.3](/filings/0000726601-26-000011.md) |
| Dividends paid | $m | [3.1 d](/filings/0000726601-24-000033.md) | [3.4 d](/filings/0000726601-24-000040.md) | [3.4 d](/filings/0000726601-26-000007.md) | [3.6](/filings/0000726601-25-000018.md) | [3.6 d](/filings/0000726601-25-000036.md) | [3.9 d](/filings/0000726601-25-000042.md) | [3.9 d](/filings/0000726601-26-000007.md) | [4.1](/filings/0000726601-26-000011.md) | [4.1 d](/filings/0000726601-25-000036.md) | [4.4 d](/filings/0000726601-25-000042.md) | [4.4 d](/filings/0000726601-26-000007.md) | [4.6](/filings/0000726601-26-000011.md) |
| Share repurchases | $m | [1.2 d](/filings/0000726601-24-000033.md) | [1.1 d](/filings/0000726601-24-000040.md) | [0.6 d](/filings/0000726601-26-000007.md) | [2.3](/filings/0000726601-25-000018.md) | [0.0 d](/filings/0000726601-25-000036.md) | [0.0 d](/filings/0000726601-25-000042.md) | [0.0 d](/filings/0000726601-26-000007.md) | [0.0](/filings/0000726601-26-000011.md) | [0.0 d](/filings/0000726601-25-000036.md) | [0.0 d](/filings/0000726601-25-000042.md) | [0.0 d](/filings/0000726601-26-000007.md) | [2.6](/filings/0000726601-26-000011.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [17.0](/filings/0000726601-23-000051.md) | [17.0](/filings/0000726601-23-000054.md) | [0.0](/filings/0000726601-24-000024.md) | [17.0](/filings/0000726601-24-000033.md) | [17.0](/filings/0000726601-24-000040.md) | [0.0](/filings/0000726601-25-000018.md) | [17.0](/filings/0000726601-25-000036.md) | [17.0](/filings/0000726601-25-000042.md) | [0.0](/filings/0000726601-26-000011.md) | [17.1](/filings/0000726601-25-000036.md) | [17.1](/filings/0000726601-25-000042.md) | [0.0](/filings/0000726601-26-000011.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 17,101,409 at 2026-04-27, from the cover of the [10-Q filed 2026-04-28](/filings/0000726601-26-000011.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.